Back to Search
DAVID CABALLERO, DMD
DMD
General Practice Dentistry
NPI: 1396882908Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
8668(FL)
Research & Publications (20)
Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcome.
PMID 19066328·Haematologica·2009
8-other
Direct patterning of anti-human serum albumin antibodies on aldehyde-terminated silicon nitride surfaces for HSA protein detection.
PMID 19296562·Small·2009
8-other
Implications of the European Organisation for Research And Treatment Of Cancer (EORTC) guidelines on the use of granulocyte colony-stimulating factor (G-CSF) for lymphoma care.
PMID 19591512·Clin Drug Investig·2009
6-review
Identification of biological markers of sensitivity to high-clinical-risk-adapted therapy for patients with diffuse large B-cell lymphoma.
PMID 19373655·Leuk Lymphoma·2009
8-other
Array comparative genomic hybridization identifies genetic regions associated with outcome in aggressive diffuse large B-cell lymphomas.
PMID 19517471·Cancer·2009
8-other
The effect of in vivo T cell depletion with alemtuzumab on reduced-intensity allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia.
PMID 18940684·Biol Blood Marrow Transplant·2008
4-observational
Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
PMID 18086801·J Clin Oncol·2008
4-observational
Prognostic factors of chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation: the national institutes health scale plus the type of onset can predict survival rates and the duration of immunosuppressive therapy.
PMID 18804047·Biol Blood Marrow Transplant·2008
8-other
Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group.
PMID 18088400·Eur J Haematol·2008
4-observational
High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
PMID 18182664·J Clin Oncol·2008
4-observational
Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis.
PMID 18711173·J Clin Oncol·2008
8-other
Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
PMID 18086796·J Clin Oncol·2008
4-observational
Reduced-intensity conditioning allogeneic transplantation from unrelated donors: evaluation of mycophenolate mofetil plus cyclosporin A as graft-versus-host disease prophylaxis.
PMID 18489992·Biol Blood Marrow Transplant·2008
3-trial
Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease.
PMID 17531780·Biol Blood Marrow Transplant·2007
8-other
Gold surface functionalization and patterning for specific immobilization of olfactory receptors carried by nanosomes.
PMID 17394286·Anal Chem·2007
8-other
Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.
PMID 17854309·Br J Haematol·2007
3-trial
A phase II multicenter study of troxacitabine in relapsed or refractory lymphoproliferative neoplasms or multiple myeloma.
PMID 17325846·Leuk Lymphoma·2007
3-trial
Chronic graft-versus-host disease: Pathogenesis and clinical management.
PMID 16789791·Drugs·2006
6-review
Treatment options in relapsed or refractory Hodgkin disease patients: the mini-BEAM regimen does exist too.
PMID 16889614·Br J Haematol·2006
8-other
Oral beclomethasone dipropionate for the treatment of gastrointestinal acute graft-versus-host disease (GVHD).
PMID 16920559·Biol Blood Marrow Transplant·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7400 N KENDALL DR, 201
MIAMI, FL 33156 - Phone
- (305) 670-0717
Quick Facts
- NPI
- 1396882908
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile